BioRender 图标

Enterocyte (epithelial���mesenchymal transition, stage 4)

Enterocyte (epithelial–mesenchymal transition, stage 4) - Editable icon of a spindle-shaped mesenchymal cell that has undergone  epithelial-mesenchymal transition, stage 4 of 4

[{"image":"https://icons.cdn.biorender.com/w75xh75/5ca75bc01177743300099897/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5ca75bc01177743300099897/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5ca75bc01177743300099895/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5ca75bc01177743300099895/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d236b/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d236b/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d236c/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d236c/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d236d/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d236d/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d236e/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d236e/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d236f/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d236f/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d2370/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d2370/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d2371/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d2371/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d2372/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d2372/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d2373/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d2373/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d2374/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d2374/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d2375/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d2375/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d2376/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d2376/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d2377/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d2377/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d2378/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d2378/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d2379/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d2379/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d237a/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d237a/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d237b/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d237b/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d237c/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d237c/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d237d/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d237d/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d237e/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d237e/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d237f/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d237f/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d2380/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d2380/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d2381/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d2381/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d2382/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d2382/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d2383/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d2383/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d2384/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d2384/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d2385/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d2385/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d2386/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d2386/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d2387/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d2387/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d2388/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d2388/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d2389/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d2389/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d238a/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d238a/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d238b/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d238b/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d238c/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d238c/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d238d/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d238d/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d238e/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d238e/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d238f/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d238f/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d2390/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d2390/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d2391/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d2391/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d2392/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d2392/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d2393/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d2393/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d2394/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d2394/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d2395/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d2395/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d2396/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d2396/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d2397/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d2397/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d2398/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d2398/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d2399/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d2399/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d239a/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d239a/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d239b/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d239b/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d239c/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d239c/5ca75b9a117774330009988e.png"}]

使用此图标 – 免费
注册无需信用卡。

此图标可在 BioRender 中完全编辑

  • 添加文本、形状及其他图标
  • 搜索 50,000 多种科学准确的图标
  • 重新着色并重新排列每一个图标、线条和标签
  • 导出或分享以满足任何使用需求
Scientist Avatars

加入 400 多万名科学家 的行列,制作可直接用于发表的图表

从图标到成品图表,只需几分钟

  • 搜索 来自 50,000 多个科学准确、经同行评审的图标
  • 自定义 添加标签、形状和更多图标——一切皆可完全编辑
  • 导出 或与协作者分享您的图表
    ‍

图标不合适?探索更多内容。

搜索涵盖 30 多个生命科学领域的 50,000 多个图标。

search icon
arrow-right

intestine,gi,gastrointestinal,intestinal,enterocyte,columnar cell,ciliated,epithelial cell,mesenchymal cell,stem cell,healing,wound,fibrosis,metastasis,cancer,epithelial,mesenchymal,EMT,transition,epithelial to mesenchymal transition,oncology

查看更多

尝试使用同义词,或注册以在应用中请求图标。

图像类型

Enterocyte (epithelial���mesenchymal transition, stage 4) icon JPEG

Enterocyte (epithelial���mesenchymal transition, stage 4) icon PNG

Enterocyte (epithelial���mesenchymal transition, stage 4) icon SVG

Enterocyte (epithelial���mesenchymal transition, stage 4) icon GIF

BioRender 图标常见问题解答

How are scientists using the Enterocyte (epithelial���mesenchymal transition, stage 4) icon in their work?

BioRender users often use the Enterocyte (epithelial���mesenchymal transition, stage 4) icon in posters, grant applications, educational materials, and graphical abstracts. It’s especially useful for projects involving Cell Types.

我可以在 BioRender 图表或科学插图中使用此图标吗?

Yes, the Enterocyte (epithelial���mesenchymal transition, stage 4) is fully integrated into BioRender’s drag-and-drop platform. You can easily add it to any scientific figure, workflow, or poster, whether you’re building from scratch or starting with a BioRender template.

Is the Enterocyte (epithelial���mesenchymal transition, stage 4) icon customizable in BioRender?

Most icons in BioRender, including the Enterocyte (epithelial���mesenchymal transition, stage 4) icon, are customizable. You can adjust icon size, colors, and positioning, and add custom labels to tailor the design to your specific research context.

Can I export figures that include the Enterocyte (epithelial���mesenchymal transition, stage 4) icon for publication or presentations?

Yes, figures containing the Enterocyte (epithelial���mesenchymal transition, stage 4) icon can be exported in multiple formats, including PNG, JPG, PDF, and SVG. High-resolution and vector exports are available on paid plans, making them ideal for journals, slide decks, and print materials.

How do I cite BioRender if I use this icon?

Unlock publication permissions with a paid plan, and include 'Created with BioRender.com' in your figure legend, or cite BioRender directly per your journal's guidelines.

Is the Enterocyte (epithelial���mesenchymal transition, stage 4) icon used in BioRender templates or poster layouts?

Many BioRender templates include icons like the Enterocyte (epithelial���mesenchymal transition, stage 4) icon — especially those focused on Cell Types. You can search BioRender’s template library or add this icon manually to any canvas.

什么是 BioRender?

BioRender is a web‑based software that helps you create scientific figures in minutes. Use this Enterocyte (epithelial���mesenchymal transition, stage 4) icon along with our library of more than 30,000 life science icons.

在 BioRender 中使用此图标

立即开始制作专业的科学图表
antibody elements3D Phospholipid illustration

正在寻找科学内容?

浏览超过 5 万个经同行评审、易于使用且免费的图标和模板。

立即寻找您的专属素材
x icon